Brought to you by 
Guidant, Miravant collaborate in cardiovascular disease
09 Jul 2004
Executive Summary
Guidant is collaborating with Miravant Medical Technologies (drugs and devices for photoselective medicine) in the development of photodynamic therapies for the minimally invasive treatment of coronary artery disease, including atherosclerosis and atherosclerotic vulnerable plaque.
Deal Industry
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Alliance
- Includes Contract
- Includes Equity
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Guidant, Miravant collaborate in cardiovascular disease
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice